Fresenius | FRE - Loan Capital

Stock Price
51.32
Daily Change
0.22 0.43%
Monthly
3.61%
Yearly
34.28%
Q1 Forecast
50.68

Fresenius reported EUR10.8B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Akzo Nobel EUR 3.67B 13M Dec/2025
Alcon AG USD 4.59B 73M Sep/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
BASF EUR 18.93B 32M Sep/2025
Bayer EUR 32.71B 1B Sep/2025
Beiersdorf EUR 132M 20M Jun/2025
DaVita Healthcare Partners USD 10.16B 19.88M Dec/2025
Demant DKK 18.98B 3.71B Dec/2025
E.ON EUR 34.92B 199M Sep/2025
Essilor EUR 9.46B 92M Dec/2025
Fresenius EUR 10.8B 1.49B Sep/2025
Fresenius Medical Care EUR 4.85B 4.49B Dec/2025
Getinge SEK 8.92B 640M Dec/2025
Givaudan CHF 4.29B 175M Jun/2024
GlaxoSmithKline GBP 14.71B 186M Dec/2025
GN Store Nord DKK 8.9B 9M Dec/2025
GRIFOLS EUR 9.09B 1.64B Sep/2025
Hikma Pharmaceutical USD 798M 191M Jun/2025
Lonza CHF 4.24B 602M Dec/2024
Merck EUR 10.45B 4.15B Sep/2025
Novartis USD 24.24B 174M Sep/2025
Philips EUR 6.93B 303M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
RWE EUR 15.64B 558M Sep/2025
Sanofi EUR 15.72B 2.45B Dec/2025
Smith & Nephew USD 3.3B 22M Dec/2025